Salute e Benessere

Advancements in Diagnostic Imaging Drive Medical Displays Market to US$4.3…

The global medical display market has been estimated to be valued at US$ 2.4 billion in 2022 and is expected to reach US$ 2.6 billion by 2023. The market's growth is predicted to be beneficial, with a CAGR of 5.3% projected from 2023 to 2033. Furthermore, the medical displays market is expected to reach a valuation of US$ 4.3 billion by 2033. This growth in healthcare and computer hardware industries signals an increasing demand for medical display platform solutions due to the constantly…
PR Newswire
01/11/2023

MRI Systems Market Worth $6.6 billion | MarketsandMarkets

Browse in-depth TOC on "MRI Systems Market" Browse in-depth TOC on "MRI Systems Market" 150 - Tables 35 - Figures 400 - Pages MRI Systems Market Scope: Ultra-high-field MRI systems segment to register significant growth rate over the forecast period of 2023-2028. Based on the field strength, the global MRI systems market is segmented into low-to-mid-field MRI systems, high & very-high-field MRI systems, and ultra-high-field MRI systems. The ultra-high-field...
PR Newswire
01/11/2023

Milliken & Company Launches OVIK Health

"Launching OVIK Health marks a new era in our work to positively impact the healthcare industry," shares Halsey Cook, president and CEO of Milliken & Company. "Through OVIK, we reaffirm our commitment to providing innovative healthcare solutions and open the door to future opportunities that can heal, protect and support patients." "Launching OVIK Health marks a new era in our work to positively impact the healthcare industry," sharesHalsey Cook, president and…
PR Newswire
01/11/2023

Thirty-One mRNA Leaders Launch First Global Organization Dedicated to Advancing…

"This is a pivotal moment for mRNA medicines," said Andy Geall, Chairman of the AMM Board and Co-Founder and Chief Development Officer of Replicate Bioscience. "The pandemic shone a bright light on the vast potential of mRNA technology to prevent disease and save lives. With the founding of the Alliance for mRNA Medicines, our community is now poised to champion scientific standards and public policies that will spur future mRNA breakthroughs - from halting chronic disease to…
PR Newswire
01/11/2023

NEW FV GEOMETRY BY KENNAMETAL FEATURES INNOVATIVE CHIP BREAKER DESIGN

FV Geometry is designed with channels that deliver coolant closer to the cutting edge—for the machinist seeking peak versatility and running uninterrupted and lightly interrupted cuts. FV Geometry is designed with channels that deliver coolant closer to the cutting edge—for the machinist seeking peak versatility and running uninterrupted and lightly interrupted cuts. FV Geometry eliminates the need to change tools for finishings operations, making it ideal for a broad range of transportation...
PR Newswire
01/11/2023

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

Click here to view the custom infographic of the Lexaria Bioscience Corp. editorial. Click here to view the custom infographic of the Lexaria Bioscience Corp.editorial. The number of people dealing with chronic, serious health challenges, including diabetes, obesity and hypertension, is spiraling out of control. The U.S. Centers for Disease Control and Prevention estimates that 37.3 million Americans have diabetes today, while nearly 100 million more adults have prediabetes. What's...
PR Newswire
01/11/2023

SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1…

Founded in 2015, SIBIONICS boasts a workforce exceeding 700 individuals, with over 40% actively engaged in research and development efforts. To date, SIBIONICS has collaborated with 1,600 hospitals on integrating the GS1 CGM for inpatient treatment, benefiting over 600,000 users worldwide in managing their diabetes. With an annual production capacity of 6,000,000 units and consistently achieving a low MARD value of 8.83% in each batch, SIBIONICS is well-equipped to serve a larger customer base…
PR Newswire
01/11/2023

Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Operating Officer and Chief Medical Officer, Matthew Davis, MD, RPh, will present at BIO-Europe, Munich, Germany, November 6-8, 2023. The presentation will be primarily focused on the recent clinical updates of intranasal foralumab, a fully human anti-CD3 monoclonal antibody, for the treatment of non-active secondary...
Nasdaq GlobeNewswire
01/11/2023

Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST”…

Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaignCAMBRIDGE, England, 1 November 2023- Jonathan Milner, the founder and one of the largest investors in Abcam plc (“Abcam” or the “Company”) (NYSE: ABCM) with ownership of 6.16% of the Company, today issued the following statement in relation to the proposed acquisition of Abcam by Danaher Corporation (NYSE: DHR) or its affiliates (“Danaher”). “After extensive feedback from the majority of Abcam's...
Nasdaq GlobeNewswire
01/11/2023

Vitamin Supplements: Growing Demand for High-Quality Nutrition to Drive…

The global vitamin supplement market is anticipated to capture a valuation of US$ 57.63 billion in 2023 and US$ 133.94 billion by 2033. The global market will likely secure a CAGR of 8.8% during the forecast period. Theglobal vitamin supplement marketis anticipated to capture a valuation of US$ 57.63 billionin 2023and US$ 133.94 billionby 2033. The global market will likely secure aCAGR of 8.8%during the forecast period. Request a sample report to preview our...
PR Newswire
01/11/2023

Medical Tubing Market worth $15.7 billion by 2028 - Exclusive Report by…

The Medical tubing market is driven by increasing demand for minimally invasive medical procedures, growing adoption of advanced medical technologies, development of novel technology, increasing demand for medical tubing in healthcare industry, and stringent regulations for medical devices. The Medical tubing market is driven by increasing demand for minimally invasive medical procedures, growing adoption of advanced medical technologies, development of novel technology, increasing demand for...
PR Newswire
01/11/2023

The Department of Health - Abu Dhabi inaugurates a nationwide Clinical Genomic…

The inaugural ceremony was attended by H.E. Mansoor Ibrahim Al Mansoori, Chairman of Department of Health – Abu Dhabi (DoH), H.E. Dr.Noura Al Ghaithi, Undersecretary at the Department of Health –Abu Dhabi, Professor SirJohn O'Reilly, President of Khalifa University, H.E. Homaid Al Shimmari Vice Chairman of the Board of Trustees of Khalifa University and representatives of local and global partners. The launch of the genomics programme comes as a continuation of the...
PR Newswire
01/11/2023

The Department of Health - Abu Dhabi launches first of its kind, nationwide…

This announcement is the first outcome of DoH's partnership with iCGD, following the Declaration of Collaboration signed inJune 2023. The unique six-month programme, delivered by experts in the field, aims to equip doctors with the necessary knowledge and skills to handle genetic and genomic issues in a clinical setting. This vital training is a core component of the National Genome Strategy to leverage data from the Emirati Genome Programme (EGP) – the world's largest genomics...
PR Newswire
01/11/2023

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate…

The randomised, placebo-controlled Phase II trial is evaluating the safety and efficacy of STS-01 applied for 6 months. A total of 158 participants have been randomised to receive one of four doses of STS-01 or placebo, with effect being measured based on improvement in the SALT score. The randomised, placebo-controlled Phase II trial is evaluating the safety and efficacy of STS-01 applied for 6 months. A total of 158 participants have been randomised to receive one of four doses of STS-01 or...
PR Newswire
01/11/2023

Khondrion announces grant of patents in the US and Europe for its lead candidate…

Research has demonstrated that sonlicromanol acts as a selective inhibitor of microsomal Prostaglandin E-synthase 1 (mPGES-1), contributing to its anti-inflammatory impact. Preclinical studies conducted in other disease models with elevated levels of cellular mPGES-1, such as particular prostate cancer cells, have displayed encouraging outcomes. These findings suggest a wider range of potential applications for sonlicromanol beyond its initial focus on primary mitochondrial diseases. Research...
PR Newswire
01/11/2023

Philips Foundation marks five years of improving access to maternal care in…

Reaching 15 million people in the region in 2022 alone [1], the foundation sets out plans to ramp up collaboration with social entrepreneursAmsterdam, the Netherlands and Nairobi, Kenya– Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year by 2030, reports today on the significant progress made in improving access to maternal healthcare in Sub-Saharan Africa. Over five years across five distinct projects, Philips Foundation has...
Nasdaq GlobeNewswire
01/11/2023

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business…

Jerry McMahon, Chief Executive Officer of STORM Therapeutics, said: "We are excited by the addition of Marguerite to the STORM leadership team as we continue to maximise collaborations for our developing pipeline of products targeting RNA modifying enzymes. Marguerite brings strategic vision to align our business with existing and new shareholders as we advance our current clinical program into additional advanced clinical studies." Jerry McMahon, Chief Executive Officer of STORM...
PR Newswire
01/11/2023

Navamedic ASA: Record high quarter with above 50 percent growth

"Over the last few months, we have demonstrated that consistent and disciplined execution of our strategy can produce significant revenue growth. It is also the first quarter where we see the YoY effect of the products acquired through Impolin. With a broad customer base across our three product areas, we have managed to maintain growth and gain traction in new and existing markets. Today's broad product portfolio also enable us to offer treatments to patients suffering from a variety of…
PR Newswire
01/11/2023

Cellectis Announces Strategic Collaboration and Investment Agreements with…

Collaboration leverages Cellectis' gene editing technologies and manufacturing capabilitiesto develop up to 10 novel cell & gene therapy candidate productsCellectis to receive up to $245M in cash (up to $220M equity investment and $25M upfront payment), with potential for additional milestones, plus tiered royaltiesNEW YORK, Nov.01, 2023(GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) today announced it has entered into (i) a Joint Research...
Nasdaq GlobeNewswire
01/11/2023

Pharming Group to participate in November investor conferences

Leiden, The Netherlands, November 1, 2023:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the month of November: Stifel 2023 Healthcare Conference, New York, November 14-15Anurag Relan, Chief Medical Officer will participate in a fireside chat, question and answer session on Tuesday, November 14 at 08:35 am ET/14:35 CET. Jefferies London Healthcare Conference...
Nasdaq GlobeNewswire
01/11/2023

Unveiling the Hottest Trends in Children, Baby, and Maternity Products at the…

Hubei Little Sun Baby Products Co., Ltd. showcased a range of top-notch baby strollers with aluminum alloy frames at the Canton Fair. The stroller and bassinet feature a dual-fold design, significantly reducing the stroller's folded size for easy storage and portability. The wheels of these strollers are made using PV integrated molding process, ensuring high wear resistance and shock absorption. They can be used on all types of roads, offering a safer and more comfortable ride for your little…
PR Newswire
01/11/2023

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based…

Aalok Agrawal, Senior Vice-President, P&G Health (Asia Pacific, India, Middle East & Africa) said, "An estimated 1 in 2 Diabetics2 and 1 in 103 Pre-diabetics suffer from Peripheral Neuropathy, while Vitamin B Deficiency affects the quality of life of ~19% of all people with diabetes,4,5. A key barrier we have recognized is that pre-diabetic and diabetic patients are often unaware of their symptoms, which leads to delay in seeking treatment, and a resultant impact on quality of life…
PR Newswire
01/11/2023

Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age…

Steve Horvath, PhD, formerly a Professor of Genetics and Biostatistics at UCLA played an instrumental role in this study with his invention of epigenetic clocks, which determine biological age using DNA samples. Horvath remarked, "Initially, I could hardly believe the profound epigenetic rejuvenation effects of E5. However, our findings are robustly supported by parallel rodent studies from different labs." Upon final analysis by Horvath and his team, there was a remarkable 67.4%…
PR Newswire
01/11/2023

Syqe Medical's Revolutionary SyqeAir Inhaler Obtains ARTG Approval in Australia…

SyqeAir is a revolutionary medical device designed to administer low, metered, and consistent doses of medicinal cannabis by inhalation, aerosolised from dried milled flowers. It has undergone clinical validation through three clinical trials as well as real-world evidence publications, demonstrating its safety and effectiveness: patients can experience a fast reduction in the intensity of pain [1], improved sleep and quality of life, with minimal psychoactive adverse events compared to...
PR Newswire
31/10/2023
Altri  Comunicati